Puma Biotechnology
PBYI
PBYI
89 hedge funds and large institutions have $115M invested in Puma Biotechnology in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.44% less ownership
Funds ownership: 60.68% → 60.25% (-0.44%)
12% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 26
Holders
89
Holding in Top 10
1
Calls
$870K
Puts
$213K
Top Buyers
| 1 | +$2.82M | |
| 2 | +$1.36M | |
| 3 | +$1.15M | |
| 4 |
Two Sigma Investments
New York
|
+$847K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$489K |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$1.72M | |
| 3 | -$1.54M | |
| 4 |
BlackRock
New York
|
-$1.39M |
| 5 |
Millennium Management
New York
|
-$489K |